Skip to main content

Table 4 Dose Escalation Regression Estimates – Inflixim ab Dependent Variables (Increase in dose for Inflixim ab 1 = yes, 0 = no)

From: Patterns of use, dosing, and economic impact of biologic agent use in patients with rheumatoid arthritis: a retrospective cohort study

Parameter

Level

Estimate

Odds-Ratio

Conditional Probability

p-value

Intercept

 

-0.0732

0.93

n.a.

0.8209

Age Group

     
 

0–34

0.0000

1.00

0.48

 
 

34–54

0.6639

1.94

0.64

0.0682

 

45–54

0.3808

1.46

0.58

0.2594

 

55+

0.0648

1.07

0.50

0.8469

HMO

HMO

-0.3810

0.68

0.39

0.0372

Pre-Index Therapy

Methotrexate

0.3900

1.48

0.58

0.0216